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Abstract
Background: Interactions between the diet and intestinal microbiota play a role in health and disease, including obesity and
related metabolic complications. There is great interest to use dietary means to manipulate the microbiota to promote
health. Currently, the impact of dietary change on the microbiota and the host metabolism is poorly predictable and highly
individual. We propose that the responsiveness of the gut microbiota may depend on its composition, and associate with
metabolic changes in the host.
Methodology: Our study involved three independent cohorts of obese adults (n = 78) from Belgium, Finland, and Britain,
participating in different dietary interventions aiming to improve metabolic health. We used a phylogenetic microarray for
comprehensive fecal microbiota analysis at baseline and after the intervention. Blood cholesterol, insulin and inflammation
markers were analyzed as indicators of host response. The data were divided into four training set – test set pairs; each
intervention acted both as a part of a training set and as an independent test set. We used linear models to predict the
responsiveness of the microbiota and the host, and logistic regression to predict responder vs. non-responder status, or
increase vs. decrease of the health parameters.
Principal Findings: Our models, based on the abundance of several, mainly Firmicute species at baseline, predicted the
responsiveness of the microbiota (AUC = 0.77–1; predicted vs. observed correlation = 0.67–0.88). Many of the predictive
taxa showed a non-linear relationship with the responsiveness. The microbiota response associated with the change in
serum cholesterol levels with an AUC of 0.96, highlighting the involvement of the intestinal microbiota in metabolic health.
Conclusion: This proof-of-principle study introduces the first potential microbial biomarkers for dietary responsiveness in
obese individuals with impaired metabolic health, and reveals the potential of microbiota signatures for personalized
nutrition.
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Introduction
The gut microbiota is an important contributor to human
health, and is emerging as a promising target for therapeutic
modulation [1,2]. Obesity-related diseases offer a prime example
where intestinal bacteria have recently been implicated as one
etiological factor [3–5]; hence modifying the gut microbiota
represents a potential strategy for successful treatment [3,6,7].
However, it is currently impossible to make practical guidelines as
to how the microbiota should be modified. Although recent
research has identified compositional and functional properties
that characterize the intestinal microbiota in healthy individuals
[8], we are lacking a definition for a healthy microbiota, mainly
because of the vast inter-individual variation [9]. Furthermore,
individuals’ responses to dietary interventions are highly variable
and poorly predictable – both in terms of host metabolism as well
as the gut microbiota – and sometimes even contrary to what was
expected from in vitro studies [10–13]. Hence, the key challenge for
the therapeutic modulation of the gut microbiota is to identify
individuals who will benefit from a given intervention, with respect
to their microbiota composition, and most importantly, with
regard to clinical health markers. Personalized nutritional and
pharmaceutical therapy, based on information of the individual’s
gut microbiota, have great prospects in the treatment of obesity
and related conditions [10,14].
PLOS ONE | www.plosone.org 1 March 2014 | Volume 9 | Issue 3 | e90702
We propose that the composition of the gut microbiota may be
informative in predicting the responses of the microbiota and of
the host to a dietary intervention. Community composition
influences the responses of its members to disturbances through
ecological and evolutionary interactions [15]; the baseline
composition of the gut microbiota is likely to influence the
responses of individual bacterial strains, and consequently those of
the bacterial community and the host. We test this hypothesis
using three independent data sets of obese individuals undergoing
different types of dietary interventions, and attempt to predict the
responses of both the host and the microbiota.
Methods
Participants and dietary interventions
We used three previously published cohorts of Finnish, Belgian
and British adults who were obese and/or had metabolic
syndrome (n = 78; 71 were obese (BMI over 30 kg/m2), and 7
were overweight (BMI 26–29) and had diagnosed metabolic
syndrome). All subjects underwent dietary interventions, which
altered the quantity and/or quality of ingested carbohydrates and
by doing so, aimed for improved metabolic health and reduced
risk for type 2 diabetes. The details of the study designs and diets,
inclusion and exclusion criteria as well as the analytical procedures
can be found in the original publications specified below. We used
microbiota and clinical data collected at the beginning and at the
end of each trial.
Studies A and B consist of a Finnish 12-week trial with 52
participants (27 females, 25 males, age 40–65, BMI 26–39 kg/m2)
fulfilling the criteria for metabolic syndrome [16]. The participants
were randomized into two intervention groups: one group (n = 28)
ate high-fiber rye bread and whole-grain pasta (hereafter referred
to as study A), and the other group (n = 24) substituted grains in
their habitual diet with low-fiber, refined wheat bread (study B).
The samples were frozen in 270uC until DNA extraction with the
Repeated Bead Beating method [17].
Study C is a Belgian 12-week trial [18] from which we included
the intervention group (n = 13, all females, BMI .30 kg/m2),
which received a daily dose of 8g inulin and 8g oligofructose. The
fecal samples were stored in 220uC until DNA extraction with the
QiAamp Stool DNA Mini Kit (Qiagen, Hilden,Germany). The kit
procedure was modified according to Salonen et al. (2010);
however, the fecal samples were not beat-beaten, but subjected to
mechanical homogenization upon vortex agitation with micro-
beads (VWR, Belgium), and the bacterial lysis was improved by
heating samples at 95uC for 5 min.
Study D is a British 10-week trial [12] in which the participants
(n = 13, all males, age 27–73, BMI 28–51), fulfilling the criteria for
metabolic syndrome, consecutively received 3 different diets after a
run-in diet for one week. The interventions, each for 3 weeks,
included a resistant-starch-enriched diet, a non-starch-polysaccha-
ride-enriched diet, and finally a weight-loss diet, low in carbohy-
drates and fat, and high in protein. We used the data collected
during the run-in diet, and at the end of the weight-loss diet. The
DNA was extracted from fresh fecal samples using the FastDNA
Spin kit for soil (Qbiogene, Carlsbad, CA).
Total blood cholesterol, HOMA (Homeostastic Model Assess-
ment, indicator of insulin sensitivity), and CRP (C-reactive protein,
indicator of systemic inflammation) values, measured before and
after the intervention, were available for all studies, except CRP
for study D, and were used as markers for host responsiveness to
the intervention. Blood sampling and analysis have been described
previously for studies A and B [16], study C [18] and study D [19].
Host blood marker values at baseline, and their relative change
after intervention are presented in Fig. S1.
As a reference for the microbiota composition and temporal
dynamics, we included 15 Finnish healthy normal-weight individ-
uals, not undergoing any intervention, from a previously published
study [20]. As obese controls we used the control group from study
C (n = 15).
Intestinal microbiota analysis
All samples were analyzed with the HITChip microarray, which
is designed for the analysis of the human gut microbiota, relies on
the identification of the V1 and V6 regions on the 16S rRNA
gene, and can detect and quantify the relative abundances of over
1000 species-level (L3) phylotypes. These can be summarized into
130 genus-like groups ($90% sequence similarity in the 16S
rRNA gene; referred to as L2) and further to 23 L1 taxa that
represent 10 phyla, the Firmicutes being further divided into
Clostridium clusters, uncultured Clostridiales and Bacilli [21].
Figure 1. Result of data normalization. Principal co-ordinates plots (with Bray-Curtis distances) show that the microbiota profiles segregate
based on the study before (panel A), but not after (panel B) data normalization.
doi:10.1371/journal.pone.0090702.g001
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Probe signals summarized to the above-mentioned phylogenetic
levels were used as indicators of bacterial abundance. The
microbiota data, generated from fecal samples collected before
and after the interventions, were extracted using min-max
normalization [22] against an in-house data collection of over
5000 microarray experiments [23]. The microarray data are
available from the Dryad Digital Repository: http://doi.org/10.
5061/dryad.bv4k7. To gain normality, the HITChip hybridiza-
tion signals were log transformed. The Pearson correlation
between the baseline and the post-intervention sample, based on
the species-level data, was calculated to define the stability of the
microbiota for each individual. The stability was used as an
indicator of the microbiota responsiveness to dietary intervention
and treated in two ways: as a continuous variable, in which case
we attempted to predict the exact stability values, or as a
categorical variable, including in the responder group those with
Pearson correlation ,0.87 (n = 14, 18% of the individuals), and in
the non-responder group those with Pearson correlation .0.92
(n = 43, 55%). The cut-off values were based on the distribution of
the stability values presented in Fig. S2.
Quantification of methanogenic archaea, not detected by the
HITChip, was carried out with quantitative PCR with previously
described primers and reaction conditions [17].
Data normalization
Unsupervised clustering and principal coordinates analysis of
the baseline microbiota revealed that the data clustered by study
(Fig. 1A). The nature of the observed differences in the microbiota
composition between the studies suggested a technical rather than
a biological basis: the gram-negative bacteria were elevated, and
the gram-positive bacteria reduced in studies C and D compared
to studies A and B (Fig. S3). The effect of PCR bias or different
analytical procedures can be excluded as all samples were
processed similarly for the microarray hybridization. Instead,
such differences can arise from the use of differentially efficient
DNA extraction methods, as the gram-negative organisms become
overrepresented with methods that fail to lyse part of the
dominant, more recalcitrant gram-positive bacteria. Such subop-
timal performance has been reported for the Qiagen kit [24], even
when preceded with short mechanical lysis [17], which was used in
study C. Indeed, the overall diversity, measured by the inverse
Simpson diversity index, was significantly lower in study C
compared to the other studies, suggesting incomplete DNA
extraction. Secondly, the relative amount of Bacteroides spp. is
sensitive to storage conditions; their amount is significantly higher
in fresh than frozen samples [24], potentially explaining the higher
abundance of Bacteroidetes in samples of study D, which were
extracted from fresh samples with mechanical lysis. To eliminate
these presumably technical differences that prevented integrated
analysis of the cohorts, we normalized the datasets: First, we
calculated the total average (log-transformed) signal intensity of
each L1 group over all samples (MT), and average signal intensities
for each L1 group in each study (MA, MB, MC, MD). For each L1
group and study, we then calculated the % difference between the
total average (MT) and the study average as DA = (MA – MT)/
MT, DB = (MB – MT)/MT, DC = (MC – MT)/MT, DD = (MD –
MT)/MT. The normalized L2 and L3 signals were obtained by
multiplying the original values with 1-D for the study and
respective L1 group. After normalization, the studies no longer
separated in PCO (Fig. 1B).
Model selection and validation
From the total (species- and genus-level) microbiota data, we
formed four training-validation data set pairs and performed
model selection and validation separately for each data set pair
following the same procedure (detailed below). Training set 1
included all studies except Study A, which acted as the validation
set; training set 2 included all studies except study B; training set 3
included all but study C; and training set 4 included all but study
D. Therefore, we had essentially four training data sets, with four
independent validation data sets.
To select and validate the predictive model for microbiota
responsiveness, we fitted linear models (separately for each training
data set) with the microbiota stability as the response variable and
the abundance of each L2 and L3 bacterial group separately as the
only explanatory variable, allowing for linear and quadratic
relationships. Although linear models assume that the relationship
between the predictor and response variable is linear, non-linear
relationships can be estimated by including a quadratic term in the
model: the relationship between the response variable may be
linearly related to the predictor squared, and thus non-linearly
(quadratically) related to the predictor. From these models we
extracted p-values for the bacterial groups, as indicators of their
potential relevance as predictors of microbiota responsiveness. We
then built full models separately for each training set, which
included all bacterial groups with p-values ,0.02, now allowing
for interactions between the bacterial groups. These models were
then reduced using AIC (Akaike Information Criterion) as the
criterion of inclusion/exclusion of variables. Several different
penalty values (2–8) were used to arrive at a set of different-sized
models. These models were then tested for their ability to predict
the independent validation data set by calculating the correlation
between the model-predicted and the observed stability values for
the validation set. The final best model was chosen as the one,
which emerged from all four training data sets, and was
adequately able to predict all four validation data sets. The same
procedure was conducted with the microbiota responder vs. non-
responder categories, using logistic regression. To assess whether
the model predicted temporal stability in general, or responsive-
Figure 2. Validation of the microbiota responsiveness model.
The model selection and validation were conducted four times, each
time leaving out one study (marked with letters A-D). The resulting
model was used to predict the stability values in the left-out study. The
dashed line represents the ideal situation where observed = predicted.
doi:10.1371/journal.pone.0090702.g002
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Figure 3. Predicting cholesterol responses to dietary intervetions. Panels A, B, C: Three cholesterol response models: cholesterol response
predicted by the microbiota stability (panel A), by the baseline abundance of E. ruminantium and C. felsineum (B), and by the baseline abundance of C.
sphenoides (C). The data were divided randomly into a training set (75% of the data) and test set (the remaining 25%), and the ROC curves represent
the ability of the models, fitted to the training data, to predict the cholesterol response (increase vs. decrease) in the test data. The ROC curve shows
the true positive rate ( = sensitivity) against the false positive rate ( = 1-specificity) for the different possible cut points of a diagnostic test. The perfect
diagnostic test would have a sensitivity = 1 and specificity = 1, and therefore the area under the curve (AUC) would be 1. A random guess would
have a ROC curve following the diagonal; curves above the diagonal indicate that the classifier works better than a random guess. Shaded areas
represent 95% confidence intervals for the ROC curve. Panels D, E, F: Comparison of cholesterol response groups (increase vs. decrease), with respect
to microbiota stability (D), E. ruminantium and C. felsineum abundance (E), and C. sphenoides abundance (F).
doi:10.1371/journal.pone.0090702.g003
Figure 4. Validation of the HOMA (panel A) and CRP (panel B) response models. In each case, one study was left out, while data from the
other studies were fitted to the model, which was then used to predict the HOMA and CRP response for the independent data set (A–D). The dashed
line represents the ideal situation where observed = predicted.
doi:10.1371/journal.pone.0090702.g004
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ness to dietary intervention specifically, we used the model to
predict temporal stabilities in the control samples.
Host responsiveness was treated as categorical (.10% increase
vs. .10% decrease, excluding the cases with ,10% change) and
continuous. Model selection and validation for HOMA and CRP
responses were conducted as detailed above. In the case of the
responses, the different studies were not directly comparable due
to different average responses per study. We corrected for this by
including the study effect in the cholesterol response models as a
fixed term, and performed model selection and validation by
dividing the total data set randomly into a training set (75% of the
data) and a validation set (25%). We present the combined result
of 5 times repeated model validation.
To ensure that the normalization did not confound the analysis,
we tested the models with the non-normalized microbiota data.
The models performed well for studies A, B, and D. The responses
within the study C, which had the most divergent L1 composition,
could only be predicted after data normalization (data not shown).
We compared the diversity, richness, and evenness of the
microbiota, as well as the presence or absence of methanogenic
archaea, and Bacteroides/Prevotella ratio with the microbiota and
host responsiveness using linear models.
Finally, we compared the baseline abundances of the organisms
that were identified as predictive, between our obese cases and
healthy controls using analysis of variance.
All analyses were conducted with R [25]. ROC (Receiver
Operating Characteristic) curves were calculated with the package
pROC [26].
Results
To study the possibility to differentiate and predict highly
individual dietary responses based on the intestinal microbiota, we
searched for associations between its baseline composition and the
degree of responsiveness of the microbiota, and of the host, to
dietary interventions.
Predicting the microbiota response
A linear model with the baseline abundances of members of
Clostridium clusters IV, IX, and XIVa, and Bacilli (Table 1) was
able to predict the overall responsiveness of the gut microbiota to
all tested dietary interventions, as demonstrated by the strong
correlations between the observed and the model-predicted values
of microbiota stability (Fig. 2). The parameter estimates are
presented in Table S1.
When treating the responsiveness as a categorical variable, and
including only the clear responders (stability,0.87) and clear non-
responders (stability . 0.92; Fig. S2), the model with the baseline
abundances of Eubacterium ruminantium and Clostridium felsineum was
able to predict with great accuracy all independent data sets (Fig.
S4): AUC (Area Under the Curve) for study A = 98.15% (95%
confidence interval: 93.02%–100%); study B = 77.78% (47.92%–
100%); study C = 100% (100%–100%); study D = 94.44%
(79.05%–100%). The non-responders were characterized by
average abundances of both species, while the responders had
either very low or very high baseline abundances of E. ruminantium
plus C. felsineum (Fig. S5).
Neither the linear nor the logistic model was able to predict the
microbiota stability of the control cases (study C, obese controls,
data not shown); the model specifically predicted responses to
dietary interventions.
Finally, we were interested in identifying the bacterial groups,
which could predict the change in bifidobacterial abundance, as
many of the diets strongly affected bifidobacteria in some, but not
all individuals. The direction and magnitude of change in
bifidobacteria was correlated only with their own baseline
abundance (Pearson correlation = 20.40, p,0.0001; Fig. S6),
indicating that intestinal bifidobacterial populations are strongly
regulated by negative density dependence.
Predicting the host response
The cholesterol, HOMA, and CRP responses varied widely
(Fig. S1), but were not interrelated. The cholesterol response was
related to the overall microbiota responsiveness, as the individuals
with a responsive microbiota all showed either a decrease (39%) or
no marked change (62%) in cholesterol levels, while only 21% of
the individuals with a non-responsive microbiota showed a
decrease in cholesterol levels, and 23% showed an increase. The
stability of the microbiota predicted the cholesterol response in the
randomly selected validation data set (with different intercepts for
different studies) with an AUC of 96% (95% CI: 89.33%–100%,
Fig. 3A, D). Moreover, the same species, which predicted the
microbiota response (E. ruminantium and C. felsineum), predicted the
cholesterol response with an AUC of 82.67% (65.17%–100%,
Fig. 3B, E). Finally, a model with only the abundance of the
species Clostridium sphenoides and different intercepts for the
different studies, predicted the cholesterol response with an
AUC of 100% (100%–100%). The abundance of C. sphenoides
was significantly (p,0.05) lower in the individuals with an increase
in cholesterol levels, as compared to those with a decrease (Fig. 3C,
F).
The HOMA response was not linked to the microbiota
response, but was predicted by a model including the baseline
abundances of members of Clostridium clusters XVI, and XVIa,
Bacilli, and Proteobacteria (Table 1, Table S1). The correlations
between the predicted and observed HOMA responses were
between 0.56 and 0.79 in the different validation data sets (Fig. 4A).
The CRP response was independent of the microbiota response,
but was predicted by a model including the baseline abundances
members of Clostridium clusters VI, XI, XIVa, and XVIII
(Table 1, Table S1). The correlations between the predicted and
observed CRP responses were between 0.46 and 0.80 in the
different validation data sets (Fig. 4B).
The diversity, richness, or evenness of the microbiota, or the
carriage of methanogenic archaea was not associated with
responsiveness (data not shown), nor was the Bacteroides/Prevotella
ratio (Pearson correlation = 0.06, p = 0.52; Fig. S7).
To confirm that the results were not platform-specific, we
included pyrosequencing data in the analysis. The data were
derived from fecal samples collected from 28 healthy adults (mean
BMI 25) before and after a four-week intervention on brown rice
and whole grain barley [27]. Most of the predictive bacteria
identified with the HITChip as predictors were not detected in this
data set, probably due to their low abundance (Table 1), so we
were unable to test the models with the sequencing data. However,
for those bacteria, which were detected, the relationship with the
microbiota responsiveness were comparable to that found in the
HITChip data (Fig. S8).
Discussion
The prognostic value of the gut microbiota
This is the first study to explicitly address the individual-specific
responses of the human microbiota to interventions, a long-know
phenomenon, which has, to date, been treated largely as random
noise. Our work revealed that rather than being random, the
response of the gut microbiota to dietary interventions can be
predicted with high accuracy based on the initial microbiota
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composition. Previously, the gut microbiota composition has been
used to successfully differentiate individuals with type 2 diabetes
[28,29] and IBD [30] from healthy controls, but this is the first
study to demonstrate the prognostic value of the gut microbiota.
Obesity is a multifactorial state, where host genes, life style and,
as recently identified, the gut microbiota [4,5] interact in a
complex and largely unknown way. Predicting how an individual
will respond to a dietary intervention is a major challenge with the
potential to revolutionize the management of obesity and
associated pathologies. Previously, adipose gene expression profiles
have been used to predict weight loss response with 80% accuracy
[31]. We have, for the first time, provided evidence that intestinal
bacteria, our microbial metabolic organ [4], can be used to predict
the host’s metabolic response to a dietary intervention. These
results were found to apply to different types of dietary
interventions, ranging from a simple addition of a prebiotic
compound (study C), to a change in the type of grains in the diet
(studies A and B), to a dietary change entailing profoundly altered
macronutrient composition (study D). It remains to be studied
whether the gut microbiota composition can be used to predict the
response to other types of dietary changes, e.g. in fat content.
Microbiota and host responses are interconnected
Our results indicate that some obese individuals gain health
benefits from a very simple and easily managed dietary change,
while others show no or even adverse responses, and may require
more profound treatment approaches. In this cohort, the
cholesterol responses were associated with the responsiveness of
the gut microbiota: a change in the gut microbiota appeared to be
necessary for the cholesterol values to lower. Similarly, Faith et al.
(2013) reported, based on sequencing data of healthy US adults,
that the change in BMI was associated with changing gut
microbiota [32]. Overall, our results confirm the previously found
link between the gut microbiota and host lipid metabolism [33,34],
and suggest that the successful improvement of lipid metabolism is
associated, and possibly dependent on, a change in the gut
microbiota composition.
The responsiveness of the microbiota appears to be a separate
phenomenon from the temporal dynamics in the absence of
intervention, as our models were unable to predict the temporal
stability of the microbiota in control individuals. This suggests that
these two traits are determined by different factors. Responsiveness
to a dietary change may, for example, reflect the primary response
of nutritionally specialized microbes, or indirect effects due to cross
feeding and/or competition. Temporal dynamics in the absence of
any specific stimulator or disturbance, in turn, may reflect e.g.
oscillatory dynamics due to density-dependent feedback (see 4.4)
or other reasons.
Predictive organisms may be bioindicators
Most strikingly, the cholesterol response could be predicted
from the abundance of a single species, Clostridium sphenoides,
measured from the fecal sample before the dietary intervention. A
decrease in cholesterol levels was observed mostly among the
individuals with high C. sphenoides abundance. Furthermore, the
abundance of C. sphenoides was in general decreased in our obese
study subjects as compared to healthy controls (Table 1). Obese
individuals with a ‘‘healthy’’ abundance of C. sphenoides thus appear
to benefit even from simple dietary interventions in terms of lipid
metabolism, while those with abnormally low abundance do not.
The abundance of C. sphenoides was not associated with the
absolute levels of cholesterol (data not shown), and therefore may
not be directly associated with cholesterol metabolism, but may
rather be an indicator of a gut ecosystem which, upon improved
diet, can contribute positively to host lipid metabolism.
Very little is known about the two organisms, which predicted
the responsiveness of the microbiota (C. felsineum and E.
ruminantium). E. ruminantium belongs to the family Lachnospiraceae,
has originally been isolated from bovine rumen, but is also part of
the human intestinal microbiota [35]. It is xylanolytic and
produces mainly formic acid, but also butyrate [36]. C. felsineum
(family Clostridiaceae) is a pectinolytic butyrate-producer [37].
Hence, both bacteria occupy the most common niche in the gut,
degradation and fermentation of indigestible carbohydrates.
The predictive bacteria identified in this study were present at a
very low abundance. Only the relative abundance of Oscillospira
guillermondii-group, which itself was not predictive but modulated
the effects of the predictive organisms (Table S1), was above 1%
(Table 1). While high analytical depth is required to detect such
minorities, their functional relevance should not be overlooked. As
an example, the acetogens, methanogenic archaea, and sulfate-
reducing bacteria, which dispose the colonic hydrogen gas
generated during fermentation, are low in abundance, but critical
for the functioning of the gut ecosystem [38]. It is very likely that
the organisms we found are not per se causative of the
responsiveness (of the host or the microbiota), but may rather be
Table 2. Predictive organisms are mostly clostridia.
L1 Phylotypes per L1 group (% of total) Predictive phylotypes (% of all predictors) Odds ratio p
Bacilli 74 (8%) 3 (14%) 1.72 NS
Clostridium cluster IV 175 (19%) 2 (9%) 0.47 NS
Clostridium cluster IX 27 (3%) 2 (9%) 3.25 NS
Clostridium cluster XI 24 (3%) 2 (9%) 3.69 NS
Clostridium cluster XVIII 5 (1%) 1 (5%) 10.11 NS
Clostridium cluster XIVa 221 (24%) 9 (41%) 1.72 NS
Clostridium cluster XVI 10 (1%) 2 (9%) 10.11 ,0.05
CC IX, XI, XVIII, XVIa, XVI 287 (31%) 16 (73%) 2.41 ,0.05
Proteobacteria 98 (11%) 1 (5%) 0.42 NS
Numbers of predictive organisms per each implicated high-level phylogenetic group (L1, see section 2.2. for explanation), compared to the total number of species in
the L1 group. Odds ratio .1 indicates that the group contains more predictive phylotypes than expected based on the total number of phylotypes in the group.
Statistical significance of the odds ratio was estimated with the Fisher’s test.
doi:10.1371/journal.pone.0090702.t002
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indicator species, particularly sensitive to the environment and
therefore informative of important structural or functional
differences between ecosystems, which lead to the differential
responses. We acknowledge that the accurate identification of
species-level phylotypes with the microarray cannot be ascer-
tained, and hence the true identities of the implicated organisms
need to be validated in further studies.
Clostridial species dominate the list of predictive organisms
(Table 2). Bacteroidetes were notably non-predictive, as was the
Bacteroides/Prevotella ratio. This is somewhat surprising as both of
these genera are, in parallel to above-mentioned Clostridiales, active
degraders of dietary polysaccharides that were essential compo-
nents of all intervention diets. The finding is interesting also in the
light of the discussion about enterotypes, which have been defined
largely by the abundance of the genera Bacteroides and Prevotella
[39]. Our findings suggest that the major determinants of the
inter-individual differences of the gut microbiota may not be the
most relevant for predictive purposes. Microbiota richness has
been positively associated with the microbiota responsiveness to
weight loss diets in obese individuals [40], but in our study, species
richness, or diversity, was not associated with the responsiveness.
However, most of the diets in our study were not weight-loss diets,
which may explain the difference.
The importance of non-linear relationships and density
dependence
Many of the predictive taxa showed non-linear associations with
the host and microbiota responsiveness, which would have been
missed, had we allowed only linear associations. Non-linear
relationships abound in nature. For example, species responses
to environmental gradients are very often unimodal, rather than
linear [41]: there is a certain preferred level, below and above
which the species does poorly. Instead of the low vs. high
abundance of a given bacterium, we found that the important
distinction was often between individuals with average vs. extreme,
either low or high, abundances. It is possible that the extreme
abundances of the identified predictor species indicate a shift in
ecosystem function, and the magnitude of the shift, rather than the
direction, is of prognostic relevance. A disturbance may reduce the
abundances of some species, allowing others to overgrow. The
direction of the shift in competitive balance may be relatively
random between individuals, depending on subtle differences in
the ecosystem structure, and hence, may be less important than
the magnitude.
Moreover, we present evidence of negative density dependence
regulating the bacterial populations in the human intestine: The
lower the baseline abundance of Bifidobacterium spp., the more they
increased during the interventions, and vice versa (Fig. S6). This is
a long-known phenomenon observed in prebiotic interventions
aiming for specific increase of bifidobacteria [42–44]. These results
indicate that ecological interactions within the microbiota, such as
intra-specific competition or phage density, act in parallel to the
intervention effects, or even override them. Yet, the importance of
baseline abundances have so far been ignored in the community-
wide microbiota analyses following dietary interventions. Negative
density dependence was evident in all bacterial groups, not only in
bifidobacteria (data not shown), which explain more generally why
certain intestinal bacteria respond to dietary changes in some, but
not all individuals, as noted in numerous studies (e.g. [16,18,45]).
Hence, when assessing the effect of an intervention on a given
bacterial group, we recommend including the baseline abundance
in the analysis to control for the impact of density dependence.
Data normalization
From the methodological perspective, our study is the first to
demonstrate how the knowledge of sample processing effects can be
utilized retrospectively, enabling meta-analysis or comparison of
samples that have been treated differently in the pre-analytical
phase. In this study, all samples were analyzed with the same
microarray platform with identical primers and workflow. There-
fore, the observed differences in the relative share of gram-negative
and gram-positive bacteria are likely to originate from differences in
DNA extraction and storage procedures. As true biological
differences cannot be excluded, the validity of our normalization
approach should be confirmed experimentally e.g. in the context of
the International Human Microbiome Standards-project (http://
www.microbiome-standards.org/). Especially in the absence of
standardized procedures, validated data normalization represents
an attractive strategy to facilitate efficient and reliable use of the
accumulating wealth of human microbiome data sets.
Concluding remarks
In summary, we present evidence that it is possible to identify
obese individuals who will benefit most from a simple dietary
intervention based on the gut microbiota composition before the
intervention. Clostridial species, in particular, were indicative of
the amenability of the gut microbiota to dietary modification,
which in turn was associated with the host’s lipid metabolism. This
concept opens potential new avenues for understanding and
treating many disorders. Moreover, it is highly likely that the same
approach can be used to identify microbial signatures, which
potentially predict the response to other perturbations, such as
antibiotics. It should be noted that our analysis represents a proof-
of-principle study. Hence, these findings do not yet support any
clinical application, but are the first step towards it.
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Figure S1 Histograms of the cholesterol (A), CRP (B),
and HOMA (C) values of all participants.
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Figure S2 Distribution of the microbiota stability
values, measured for each individual by calculating the
Pearson correlation for the microbiota profiles collected
before and after the dietary intervention. Cut-offs used to
classify responders (stability ,0.87) and non-responders (stability
.0.92) are marked with vertical lines.
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Figure S3 Relative abundances of the dominant phyla in
the different studies (A–D) before data normalization.
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Figure S4 Model validation for the classification of
individuals into microbiota responders and non-re-
sponders based on baseline microbiota. The model was
fitted to four training data sets and used to predict four validation
data sets A–D, shown in the different panels. The ROC curves
present the model performance in each training-validation data set
pair (shaded areas represent the 95% confidence intervals).
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Figure S5 The summed abundance of two clostridial
species differentiates microbiota-responders from non-
responders; responders have either very low or very
high abundances, while non-responders have average
abundances of these organisms.
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interventions.
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mean = 0, and sd = 1.
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